Impact of clinical pharmacist video-based education on self-care and glycemic control in Sudanese adults with type 2 diabetes: A pre-post interventional study

Badi, Safaa and Zainelabdien Suliman, Sara and Almahdi, Rayan and Aldomah, Mohammed A and Elkheir, Habab Khalid and Mohamed Izham, Mohamed Ibrahim and Ahmed, Mohamed H (2025) Impact of clinical pharmacist video-based education on self-care and glycemic control in Sudanese adults with type 2 diabetes: A pre-post interventional study. Exploratory Research in Clinical and Social Pharmacy, 19 (100617). pp. 1-10. ISSN 2667-2766

Text Ahmed et al. ERCSP 2025 19.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (1MB)

Abstract

Background: Diabetes affects various body systems, increasing the risk of complications. Objectives: This study assessed the impact of clinical pharmacist-associated education on diabetes self-care practices and glycemic control in Sudanese individuals with Type 2 Diabetes Mellitus (T2DM). Design and methods: This quasi-experimental study with no control group recruited 110 adults with T2DM from a diabetes clinic over 12 months using simple random sampling. We collected data through interviews and calls. Participants received 12 educational videos covering diabetes management. The intervention was video-based and delivered over 5 months. We analyzed data using SPSS version 28. Results: The mean age of participants was 56.2 ± 10.3 years. Self-care practices significantly improved over time. Fasting blood glucose (FBG) levels decreased by 16.7 mg/dL at 6 months (p = 0.009) and 41.9 mg/dL at 12 months (p < 0.001). Two-hour postprandial glucose levels dropped by 18.7 mg/dL at 6 months (p = 0.006) and 61.8 mg/dL at 12 months (p < 0.001). HbA1c levels decreased by 1 % at6 months (p < 0.001) and 1.9 % at 12 months (p < 0.001). The effect size (Cohen’s d) was increased from 0.26 at 6 months to 0.74 at 12 months. Similarly, it was increased for 2hrsPPG from 0.2 at 6 months to 0.74 at 12 months. For HbA1c, it was increased from 0.62 at 6 months to 1.25 at 12 months, indicating clinically meaningful improvement in long-term glycemic control following the pharmacist intervention. LDL decreased by 9.2 mg/dL at 12 months (p < 0.001), and HDL increased by 5.5 mg/dL at 12 months (p = 0.002). Changes in BUN and serum creatinine were insignificant. Conclusion: Clinical pharmacist education improved diabetes self-care practices and metabolic outcomes, including glycemic control and lipid profiles, demonstrating its role in achieving therapeutic goals for patients with T2DM.

Actions (login required)

View Item